Neuronetics

IPO

We renew lives by transforming neurohealth

Neuronetics was founded in 2003, is headquartered in Malvern, United States, and has $109.3M in recorded funding across 4 rounds.

Headquarters
Malvern
Founded
2003
Business Model
B2B
Total Funding
$109.3M
Last Round
$15.0M Series G+Jun 2017
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

Neuronetics, Inc. is a publicly traded medical device company founded in 2003 and headquartered in Malvern, Pennsylvania. It created NeuroStar Advanced Therapy, the market-leading transcranial magnetic stimulation (TMS) system for treating adults with major depressive disorder, backed by the largest clinical data set of any TMS therapy and the world's largest depression Outcomes Registry. NeuroStar has delivered more than 8.8 million treatments to over 235,000 patients, is covered by insurance plans for more than 300 million Americans, and is supported by the largest direct sales and customer support teams in the TMS industry.

Summary

Neuronetics is a Healthcare company based in Malvern, United States, founded in 2003. It has raised $109.3M in total across 4 rounds, most recently a $15.0M Series G+ round in Jun 2017. Investors include Perceptive Credit Holdings IV, GE Ventures and Polaris Partners.

Tech & App Stack

17 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Debt FinancingDebt FinancingAug 2025
$10.0M

Sign up to see all 6 events

Funding: Series D through Series G+. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neuronetics on Indexed.vc
<a href="https://indexed.vc/companies/neuronetics"><img src="https://indexed.vc/api/badge/company/neuronetics" alt="Neuronetics on Indexed.vc" width="260" height="76" /></a>